Literature DB >> 22197124

Lacosamide use in refractory idiopathic primary generalized epilepsy.

Andro Zangaladze1, Christopher Skidmore.   

Abstract

Treatment of refractory idiopathic primary generalized epilepsy can be very challenging, with limited drug options, especially in young women of childbearing age. Here we describe the cases of two young women with refractory idiopathic primary generalized epilepsy refractory to multiple antiepileptic drugs in monotherapy or combination before achieving a long-term remission with adjunctive lacosamide (LCS) treatment. Larger, randomized prospective studies are necessary to establish the effectiveness of lacosamide in these patients.
Copyright © 2011. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22197124     DOI: 10.1016/j.yebeh.2011.10.023

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  6 in total

Review 1.  Pharmacological Management of the Genetic Generalised Epilepsies in Adolescents and Adults.

Authors:  Linda J Stephen; Martin J Brodie
Journal:  CNS Drugs       Date:  2020-02       Impact factor: 5.749

2.  Status epilepticus developing during lacosamide monotherapy.

Authors:  Savvas S Papacostas
Journal:  BMJ Case Rep       Date:  2015-01-27

3.  Safety and efficacy of intravenous lacosamide for adjunctive treatment of refractory status epilepticus: a comparative cohort study.

Authors:  Raoul Sutter; Stephan Marsch; Stephan Rüegg
Journal:  CNS Drugs       Date:  2013-04       Impact factor: 5.749

Review 4.  Practical Use of Newer Antiepileptic Drugs as Adjunctive Therapy in Focal Epilepsy.

Authors:  Martin J Brodie
Journal:  CNS Drugs       Date:  2015-11       Impact factor: 5.749

5.  Lacosamide for refractory generalized tonic-clonic seizures of non-focal origin in clinical practice: A clinical and VEEG study.

Authors:  Belén Abarrategui; María Eugenia García-García; Rafael Toledano; Beatriz Parejo-Carbonell; Antonio Gil-Nagel; Irene García-Morales
Journal:  Epilepsy Behav Case Rep       Date:  2017-08-24

6.  Efficacy and safety of adjunctive lacosamide in the treatment of primary generalised tonic-clonic seizures: a double-blind, randomised, placebo-controlled trial.

Authors:  David G Vossler; Susanne Knake; Terence J O'Brien; Masako Watanabe; Melissa Brock; Björn Steiniger-Brach; Paulette Williams; Robert Roebling
Journal:  J Neurol Neurosurg Psychiatry       Date:  2020-08-18       Impact factor: 10.154

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.